Cancer drug developer Curis now has the FDA’s blessing to resume one of two clinical trials that were halted in the spring after a patient died. Curis said Thursday that…
Sanofi is officially out of the race to develop a breast cancer drug in pill form that could compete with a blockbuster injection therapy. The pharmaceutical giant’s challenger, amcenestrant, has…
Gilead Sciences now has more clinical data showing that breast cancer drug Trodelvy has helped patients live longer. The FDA already has that data, too, as the drugmaker said Monday…
Shares of Gilead Sciences Inc. GILD, +5.06% rose 4.9% in Monday trading after the company said in a news release that Trodelvy improved overall survival rates in people with HR+/HER2-…
In 2017, actor and singer Olivia Newton-John announced that she had breast cancer for the third time. Two years later, she began suffering from back pain and had to cancel…
AstraZeneca and Daiichi Sankyo’s Enhertu drug is on a hot streak, winning FDA approval for lung cancer, marking the second positive regulatory decision in a week. The The FDA approval…
A breast cancer drug from AstraZeneca and Daiichi Sankyo is now available FDA approval to address a brand new category of disease, a solution that allows targeted therapy to reach…
Health insurer AmeriHealth New Jersey has partnered with Thyme Care, an oncology care management company, to help its members cope with cancer diagnoses. The new union starts on 1 January…
Amidst reaching an acquisition deal that brings Ipsen a commercialized drug for follicular lymphoma, the Paris-based drugmaker is expanding its reach in cancer through license deal which took him into…
A precision medicine is only as good as its target. Although targeted therapies now target many types of cancer, tumors still often develop mutations that help them escape the drug.…